Eurogentec’s Biologics Facility Successfully Completes US FDA Inspection – EON: Enhanced Online News (press release)
Eurogentec's Biologics Facility Successfully Completes US FDA Inspection EON: Enhanced Online News (press release) This FDA status allows Eurogentec to manufacture a commercial bulk parenteral biopharmaceutical for one of its clients for the US market. “We are very pleased with the status we have received from the FDA; this demonstrates our continued commitment to ... |

0 Comments
You can be the first one to leave a comment.